Seaport Therapeutics, Inc. Common Stock ROE

The ROE as of November 2026 (TTM) for Seaport Therapeutics, Inc. Common Stock (SPTX) is -48.72%

According to Seaport Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current ROE is -48.72%. This represents a change of -28127.07% compared to the average of 0.17% of the last 4 quarters.

Seaport Therapeutics, Inc. Common Stock (SPTX) Historical ROE (quarterly & annually)

How has SPTX ROE performed in the past?

The mean historical ROE of Seaport Therapeutics, Inc. Common Stock over the last ten years is 80.91%. The current -48.72% ROE has changed -160.21% with respect to the historical average. Over the past ten years (40 quarters), SPTX's ROE was at its highest in in the March 2026 quarter at 21.98%. The ROE was at its lowest in in the June 2026 quarter at -14.81%.

Seaport Therapeutics, Inc. Common Stock (SPTX) ROE by Quarter and Year

Discovering the peaks and valleys of Seaport Therapeutics, Inc. Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Seaport Therapeutics, Inc. Common Stock (SPTX) Average ROE

How has SPTX ROE performed in the past?

The current ROE of Seaport Therapeutics, Inc. Common Stock (SPTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Seaport Therapeutics, Inc. Common Stock (SPTX) ROE vs. Peers

How is SPTX’s ROE compared to its peers?

Seaport Therapeutics, Inc. Common Stock’s ROE is greater than LB Pharmaceuticals Inc Common Stock (-25.91%), greater than Rapport Therapeutics, Inc. Common Stock (-29.02%), greater than Neumora Therapeutics, Inc. Common Stock (-242.28%), greater than MapLight Therapeutics, Inc. (-63.84%), greater than GH Research PLC (-20.86%), greater than Vanda Pharmaceuticals Inc. (-106.94%), greater than Quantum BioPharma Ltd. (-413.07%), greater than Pasithea Therapeutics Corp. (-49.49%), greater than Contineum Therapeutics, Inc. (-24.73%), greater than Serina Therapeutics, Inc. (-222.42%),

Build a custom stock screener for Seaport Therapeutics, Inc. Common Stock (SPTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seaport Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Seaport Therapeutics, Inc. Common Stock (SPTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Seaport Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.